Alucio™ Introduces New AI-Driven Content Assembly Feature in Beacon [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
SAN FRANCISCO Dec. 3, 2024 /PRNewswire-PRWeb/ -- Alucio™, a fast-growing provider of cloud-based software for the life sciences industry, today announced a new enhancement that leverages its artificial intelligence (AI) capabilities in the Beacon platform. Beacon is a modern content activation and Healthcare Professional (HCP) engagement platform built specifically for Medical Science Liaisons (MSLs), Medical Affairs professionals, and Market Access teams. To date, through its presentation builder feature, Beacon has provided a compliant, easy-to-use interface that allows field users to collate approved materials from various approved content sources into one seamless, customized presentation. Because this assembly process is governed by the organization's medical and regulatory parameters, users can meet the specific information needs of their audiences while adhering to company and industry guidelines. Using AI, Beacon is now able to significantly enhance this capability with a
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- GIVLAARI® (givosiran injection) Now Widely Reimbursed in Canada For the Treatment of Acute Hepatic Porphyria (AHP) in Adults [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch For Future Potential [Yahoo! Finance]Yahoo! Finance
- Exploring Three High Growth Tech Stocks For Potential Portfolio Enhancement [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
ALNY
Earnings
- 10/31/24 - Beat
ALNY
Sec Filings
- 12/13/24 - Form 4
- 12/12/24 - Form 144
- 11/27/24 - Form 4
- ALNY's page on the SEC website